USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Aug 8, 2022 | Jun 2022 | - | - | $-0.35 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Aug 8, 2022 | Jun 2022 | - | - | $22.76M |
Castle Biosciences, Inc's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 2022.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 6 | $-1.50 | $-2.44 | $-0.66 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 1 / 0 | $-1.45 | $-1.11 | $-1.11 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 6 | $113.41M | $104.00M | $121.10M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| May 9, 2022 | Mar 2022 | $-0.71 | - | - |
| Feb 28, 2022 | Dec 2021 | $-0.47 | $-0.25 | 46.81% |
| Nov 8, 2021 | Sep 2021 | $-0.41 | $-0.47 | -16.05% |
| Aug 9, 2021 | Jun 2021 | $-0.37 | $-0.35 | 4.37% |
| May 10, 2021 | Mar 2021 | $-0.24 | $-0.17 | 27.66% |
| Mar 8, 2021 | Dec 2020 | $-0.12 | $-0.23 | -88.52% |
| Nov 9, 2020 | Sep 2020 | $-0.12 | $-0.23 | -100.00% |
| Aug 10, 2020 | Jun 2020 | $-0.40 | $-0.08 | 79.87% |
| May 11, 2020 | Mar 2020 | $-0.15 | $0.03 | 120.34% |
| Mar 10, 2020 | Dec 2019 | $-0.20 | $0.11 | 154.11% |
| Nov 11, 2019 | Sep 2019 | $-0.31 | $0.05 | 116.39% |
| Sep 3, 2019 | Jun 2019 | $-0.79 | $-0.13 | 83.13% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Feb 28, 2022 | Dec 2021 | $-1.47 | $-1.24 | - |
| Mar 8, 2021 | Dec 2020 | $-0.41 | $-0.51 | - |
| Mar 10, 2020 | Dec 2019 | $-1.37 | $0.03 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| May 9, 2022 | Mar 2022 | $24.88M | - | - |
| Feb 28, 2022 | Dec 2021 | $23.36M | $25.04M | 1.07% |
| Nov 8, 2021 | Sep 2021 | $22.97M | $23.48M | 1.02% |
| Aug 9, 2021 | Jun 2021 | $18.92M | $22.76M | 1.20% |
| May 10, 2021 | Mar 2021 | $22.81M | $22.81M | 1.00% |
| Mar 8, 2021 | Dec 2020 | $15.74M | $17.30M | 1.10% |
| Nov 9, 2020 | Sep 2020 | $14.99M | $15.22M | 1.02% |
| Aug 10, 2020 | Jun 2020 | $8.80M | $12.71M | 1.44% |
| May 11, 2020 | Mar 2020 | $13.79M | $17.42M | 1.26% |
| Mar 10, 2020 | Dec 2019 | $0.00 | $17.63M | - |
| Nov 11, 2019 | Sep 2019 | $9.45M | $14.77M | 1.56% |
| Sep 3, 2019 | Jun 2019 | $10.74M | $10.74M | 1.00% |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Feb 28, 2022 | Dec 2021 | $92.41M | $94.08M | 1.81% |
| Mar 8, 2021 | Dec 2020 | $61.12M | $62.65M | 2.50% |
| Mar 10, 2020 | Dec 2019 | $0.00 | $51.87M | - |
CSTL's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 30, 2022.
Castle Biosciences, Inc's previous earnings date was May 9, 2022 for its fiscal quarter ended Mar 31, 2022.
Castle Biosciences, Inc's previous annual earnings date was Feb 28, 2022 for its fiscal year ended Dec 31, 2021.
CSTL's earnings per share (EPS) was $-1.24, beating the consensus analysts forecast of $-1.47 by -15.65% , and lower than the previous year's EPS (Dec 2020) by 143.14%.
Revenues were $94.08M, better than the forecast of $92.41M by 1.81%, and up by 50.18% from previous year's revenue.
The company reported a net income of $-31.29M.
Castle Biosciences, Inc reported a free cash flow of $-22.47M for its fiscal year, compared to $5.11M a year ago.
The company ended the fiscal year with $16.16M in total debt. lala
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
